SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000921895-20-002429
Filing Date
2020-09-17
Accepted
2020-09-17 16:12:32
Documents
2

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO THE SCHEDULE 13D sc13da205735004_09162020.htm SC 13D/A 223360
2 JOINT FILING AGREEMENT ex991to13da205735004_091620.htm EX-99.1 7786
  Complete submission text file 0000921895-20-002429.txt   232718
Mailing Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016
Business Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016 732-980-4500
ENZON PHARMACEUTICALS, INC. (Subject) CIK: 0000727510 (see all company filings)

IRS No.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-35587 | Film No.: 201181337
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 630 FIFTH AVENUE SUITE 2260 NEW YORK NY 10020
Business Address
COUCHMAN JONATHAN (Filed by) CIK: 0001265094 (see all company filings)

Type: SC 13D/A